Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Accounts Payable & Accrued Expense : ¥1,351 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co Accounts Payable & Accrued Expense?

Jilin Aodong Pharmaceutical Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥1,336 Mil) to Dec. 2023 (¥1,426 Mil) but then declined from Dec. 2023 (¥1,426 Mil) to Mar. 2024 (¥1,351 Mil).

Jilin Aodong Pharmaceutical Group Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,017 Mil) to Dec. 2022 (¥1,424 Mil) and increased from Dec. 2022 (¥1,424 Mil) to Dec. 2023 (¥1,426 Mil).

Jilin Aodong Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

Jilin Aodong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

892.08

986.73

1,017.38

1,423.92

1,426.32

Jilin Aodong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,261.59	1,640.14	1,336.07	1,426.32	1,350.80

Jilin Aodong Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 2158, Jidong Street, Dunhua, CHN, 133700

Website

http://www.jlaod.com

Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.

Executives

Guo Shu Qin	Directors, executives
Wang Zhen Yu	Directors, Directors, and Executives
Zhao Da Long	Director
Yang Kai	Directors, executives
Li Xiu Lin	Director
Zhang Shu Yuan	Directors, executives
Chen Yong Feng	Supervisors
Zhang Ming Jing	Supervisors
Li An Ning	Supervisors
Lin Xiao Lin	Executives
Ying Gang	Director
Guo Li	Supervisors
Xu Dong Lin	Supervisors
Zhu Yan	Directors, executives
Li Li Ping	Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines